Nevro Total Liabilities 2013-2024 | NVRO
Nevro total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Nevro Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $343 |
| 2022 | $279 |
| 2021 | $271 |
| 2020 | $401 |
| 2019 | $253 |
| 2018 | $218 |
| 2017 | $205 |
| 2016 | $182 |
| 2015 | $57 |
| 2014 | $30 |
| 2013 | $8 |
| 2012 | $5 |
| Nevro Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $322 |
| 2024-06-30 | $329 |
| 2024-03-31 | $318 |
| 2023-12-31 | $343 |
| 2023-09-30 | $276 |
| 2023-06-30 | $275 |
| 2023-03-31 | $273 |
| 2022-12-31 | $279 |
| 2022-09-30 | $281 |
| 2022-06-30 | $294 |
| 2022-03-31 | $292 |
| 2021-12-31 | $271 |
| 2021-09-30 | $263 |
| 2021-06-30 | $241 |
| 2021-03-31 | $409 |
| 2020-12-31 | $401 |
| 2020-09-30 | $399 |
| 2020-06-30 | $379 |
| 2020-03-31 | $245 |
| 2019-12-31 | $253 |
| 2019-09-30 | $250 |
| 2019-06-30 | $246 |
| 2019-03-31 | $244 |
| 2018-12-31 | $218 |
| 2018-09-30 | $207 |
| 2018-06-30 | $204 |
| 2018-03-31 | $202 |
| 2017-12-31 | $205 |
| 2017-09-30 | $194 |
| 2017-06-30 | $180 |
| 2017-03-31 | $175 |
| 2016-12-31 | $182 |
| 2016-09-30 | $172 |
| 2016-06-30 | $166 |
| 2016-03-31 | $46 |
| 2015-12-31 | $57 |
| 2015-09-30 | $43 |
| 2015-06-30 | $36 |
| 2015-03-31 | $33 |
| 2014-12-31 | $30 |
| 2014-09-30 | $9 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2012-12-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.184B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.781B | 26.81 |
| Intuitive Surgical (ISRG) | United States | $217.430B | 113.68 |
| Alcon (ALC) | Switzerland | $43.790B | 29.30 |
| Edwards Lifesciences (EW) | United States | $40.720B | 25.86 |
| IQVIA Holdings (IQV) | United States | $37.284B | 20.54 |
| IDEXX Laboratories (IDXX) | United States | $35.259B | 41.52 |
| DexCom (DXCM) | United States | $34.017B | 51.23 |
| Waters (WAT) | United States | $24.246B | 35.85 |
| STERIS (STE) | Ireland | $21.575B | 24.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.893B | 0.00 |
| Hologic (HOLX) | United States | $16.069B | 17.45 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.597B | 13.96 |
| Globus Medical (GMED) | United States | $12.707B | 32.18 |
| Sysmex ADR (SSMXY) | Japan | $11.852B | 37.16 |
| Penumbra (PEN) | United States | $10.587B | 103.70 |
| Masimo (MASI) | United States | $9.271B | 44.86 |
| Glaukos (GKOS) | United States | $8.829B | 0.00 |
| Teleflex (TFX) | United States | $8.395B | 13.39 |
| Integer Holdings (ITGR) | United States | $4.744B | 26.89 |
| Inari Medical (NARI) | United States | $4.650B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.570B | 0.00 |
| Veracyte (VCYT) | United States | $3.336B | 100.12 |
| LivaNova (LIVN) | United Kingdom | $2.642B | 15.25 |
| Nihon Kohden (NHNKY) | Japan | $2.325B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.299B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.235B | 20.10 |
| TransMedics (TMDX) | United States | $2.080B | 65.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.918B | 10.02 |
| Alphatec Holdings (ATEC) | United States | $1.614B | 0.00 |
| Artivion (AORT) | United States | $1.290B | 85.50 |
| RxSight (RXST) | United States | $1.286B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.979B | 0.00 |
| AxoGen (AXGN) | United States | $0.831B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.787B | 18.55 |
| IRadimed (IRMD) | United States | $0.752B | 40.63 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.729B | 12.39 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.657B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.587B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.576B | 30.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.496B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.494B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.488B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.486B | 0.00 |
| NeuroPace (NPCE) | United States | $0.419B | 0.00 |
| CVRx (CVRX) | United States | $0.418B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.417B | 22.57 |
| Alpha Tau Medical (DRTS) | Israel | $0.279B | 0.00 |
| Inogen (INGN) | United States | $0.258B | 0.00 |
| Accuray (ARAY) | United States | $0.229B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.120B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.115B | 12.26 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| 908 Devices (MASS) | United States | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.084B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.083B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.076B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Neuronetics (STIM) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| Lucid Diagnostics (LUCD) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |